Who owns the RETHINK ADHD SYMPTOM CONTROL trademark?

The RETHINK ADHD SYMPTOM CONTROL trademark is owned by Supernus Pharmaceuticals, Inc..

What class is the RETHINK ADHD SYMPTOM CONTROL trademark registered in?

The RETHINK ADHD SYMPTOM CONTROL trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RETHINK ADHD SYMPTOM CONTROL?

The USPTO serial number for RETHINK ADHD SYMPTOM CONTROL is 90287870.

What is the registration number for RETHINK ADHD SYMPTOM CONTROL?

RETHINK ADHD SYMPTOM CONTROL is registered under USPTO registration number 6668162.

RET

USPTO Trademark Record

REGISTERED

RETHINK ADHD SYMPTOM CONTROL

SN 90287870·Reg 6668162·Filed Oct 29, 2020

Owner Supernus Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

RETHINK ADHD SYMPTOM CONTROL (Serial No. 90287870), Registration No. 6668162, is a registered US trademark filed on Oct 29, 2020 by Supernus Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: March 08, 2028

Mark Intelligence

RETHINK ADHD SYMPTOM CONTROL (Reg. #6668162) is a registered US trademark that has been protecting its owner, Supernus Pharmaceuticals, Inc., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 29, 2020

SERIAL

90287870

REG#

6668162

REGISTERED

Mar 08, 2022

Owner

Applicant

Supernus Pharmaceuticals, Inc.

Entity

Corporation

State

Address

1550 East Gude Drive, Rockville, MD, 20850

Country

Attorney

NameMark Simpson

Law firm

Mark Simpson SAUL EWING ARNSTEIN & LEHR

Docket

356969.00062

Address

1500 MARKET STREET, CENTRE SQUARE WEST, 38TH FLOOR, PHILADELPHIA, PA 19102-2186, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateOct 29, 2020

Serial Number90287870

Registration No.6668162

Registration DateMar 08, 2022

Status DateMar 08, 2022

Published for OppositionMay 18, 2021

Mark TypeStylized characters

Attorney Docket356969.00062

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 25, 2021

First use in commerce: Jul 19, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

16 events

REGISTERED-PRINCIPAL REGISTER

Mar 08, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 03, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 02, 2022

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Jan 31, 2022

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 28, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Jan 13, 2022

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jan 13, 2022

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 13, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 18, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 18, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 28, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

WITHDRAWN FROM PUB - OG REVIEW QUERY

Apr 13, 2021

WITHDRAWN FROM PUB - OG REVIEW QUERY

ASSIGNED TO EXAMINER

Mar 30, 2021

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 30, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 22, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 02, 2020

NEW APPLICATION ENTERED

RETHINK ADHD SYMPTOM CONTROL

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Supernus Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Mark Simpson

Resources

Company